Stereotaxis announced on November 20, 2024, that physicians at Hospital da Luz in Lisbon, Portugal, successfully treated their first patients using the advanced Genesis Robotic Magnetic Navigation (RMN) System. Hospital da Luz Lisboa, a University Hospital affiliated with Portugal's largest health group, Luz Saude, has a history of performing over 4,000 robotic cardiac ablation procedures.
The Genesis System is the latest advancement in Robotic Magnetic Navigation technology, designed to bring robotic precision and safety to cardiac ablation procedures. This technology is crucial for treating cardiac arrhythmias, which are abnormal heart rhythms that can increase the risk of stroke, heart failure, and sudden cardiac arrest.
This expansion of the long-term relationship with Hospital da Luz highlights the continued clinical value and adoption of Stereotaxis' robotic innovations. The successful integration of the Genesis System supports the company's efforts to improve patient care and advance clinical science in the field of interventional cardiology.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.